Journal of surgical oncology

publication venue for

Hypogonadism, frailty, and postoperative outcomes among men undergoing radical nephrectomy. 2024
Reconstruction of oncologic upper extremity defects with fibula free flaps has high union rates and excellent functional outcomes. 2023
Preoperative glucose in surgical oncology patient is not associated with postoperative outcomes after adjustment for frailty.. 128. 2023
Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group.. 127. 2023
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis.. 127. 2022
Risk factors for venous thromboembolism (VTE) after adrenalectomy for adrenal cortical neoplasms. 2022
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients.. 126. 2022
Effects of COVID-19 on mastectomy and breast reconstruction rates: A national surgical sample.. 126. 2022
Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.. 125. 2022
Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma. 2021
Travel distance is associated with stage at presentation and laryngectomy rates among patients with laryngeal cancer.. 124. 2021
Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.. 122. 2020
Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status.. 123. 2020
Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk?. 122. 2020
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis.. 122. 2020
Is minimally invasive surgery of lesions in the right superior segments of the liver justified? A multi-institutional study of 245 patients.. 122. 2020
Sentinel lymph node biopsy predicts systemic recurrence in digital papillary adenocarcinoma.. 122. 2020
Preparation for the complex general surgical oncology boards-Level I evidence and best sources of acquiring knowledge.. 122. 2020
Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.. 122. 2020
Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades.. 121. 2020
Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.. 121. 2020
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract.. 121. 2020
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy.. 121. 2020
Association between patient age and the risk of mortality following local recurrence of a sacral chordoma. 2019
Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry. 2019
Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma. 2019
Impact of intraoperative remifentanil on postoperative pain and opioid use in thyroid surgery.. 120. 2019
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.. 120. 2019
Elective neck dissection (END) and cN0 hard palate and upper gingival cancers: A National Cancer Database analysis of factors predictive of END and impact on survival.. 120. 2019
Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.. 119. 2018
Comparison of gastric cancer survival after R0 resection in the US and China.. 118. 2018
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.. 118. 2018
Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.. 118. 2018
A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.. 118. 2018
Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes.. 118. 2018
Importance of wide re-resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution.. 117. 2018
Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma.. 117. 2017
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.. 117. 2017
Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database.. 116. 2017
Recurrence patterns following irreversible electroporation for hepatic malignancies.. 115. 2017
Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).. 116. 2017
The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.. 115. 2017
Evolving application of minimally invasive cancer operations at a tertiary cancer center.. 115. 2017
Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.. 115. 2017
Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.. 115. 2016
Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.. 114. 2016
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.. 114. 2016
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.. 114. 2016
Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.. 114. 2016
Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.. 114. 2016
Routine sampling of internal mammary lymph nodes during microsurgical breast reconstruction-Experience based on 524 microsurgical breast reconstructions.. 114. 2016
Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.. 113. 2016
Young patients with synchronous colorectal liver metastases.. 113. 2016
Initial report of near-infrared fluorescence imaging as an intraoperative adjunct for lymph node harvesting during robot-assisted laparoscopic gastrectomy.. 113. 2016
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.. 113. 2016
Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.. 113. 2015
Surgical site infection impact of pelvic exenteration procedure.. 112. 2015
Proposal for anatomical classification of the superior pole in thyroid surgery.. 112. 2015
Differences in gastric cancer survival between the U.S. and China.. 112. 2015
Liver resection and ablation for metastatic melanoma: A single center experience.. 111. 2015
Prevalence of breast masses and barriers to care: results from a population-based survey in Rwanda and Sierra Leone.. 110. 2014
External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer.. 110. 2014
Predicting the development of brain metastases in patients with local/regional melanoma.. 109. 2014
Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.. 109. 2013
Splenectomy to treat splenic lesions: an analysis of 148 cases at a cancer center.. 108. 2013
A new care paradigm in geriatric head and neck surgical oncology.. 108. 2013
Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma.. 107. 2012
Bone tumor reconstruction with the Ilizarov method.. 107. 2012
Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease.. 106. 2012
The diagnostic value of nipple discharge cytology: breast imaging complements predictive value of nipple discharge cytology.. 106. 2012
Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis.. 106. 2012
Self-expanding metal stents (SEMS) for patients with advanced esophageal cancer in Malawi: an effective palliative treatment.. 105. 2011
Meeting the 12 lymph node (LN) benchmark in colon cancer.. 102. 2010
Risk-reducing surgery in FAP: role for surgeons beyond the incision.. 101. 2010
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.. 100. 2009
Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.. 100. 2009
Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.. 100. 2009
Residual disease after re-excision lumpectomy for close margins.. 99. 2009
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).. 98. 2008
Is pleomorphic lobular carcinoma really a distinct clinical entity?. 98. 2008
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases.. 97. 2008
Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.. 97. 2008
Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis.. 97. 2008
Sentinel lymph node biopsy for breast cancer: how many nodes are enough?. 96. 2007
Reconstruction of maxillectomy and midfacial defects with free tissue transfer.. 94. 2006
Opening the "gift box": a systematic approach to expose the thyroid and superior thyroid vessels in complicated thyroid surgery.. 93. 2006
Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.. 91. 2005
Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy.. 87. 2004
Efficacy of sentinel lymph node biopsy in male breast cancer.. 86. 2004
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection.. 83. 2003
Are the axillary lymph nodes treated by standard tangent breast fields?. 81. 2002
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy.. 70. 1999
Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors.. 70. 1999
Deep venous thrombosis after orthopedic surgery in adult cancer patients.. 68. 1998
Expression of retinoid-responsive genes occurs in colorectal carcinoma-derived cells irrespective of the presence of resistance to all-trans retinoic acid.. 66. 1997
Long-term survival and DNA ploidy in advanced epithelial ovarian cancer.. 64. 1997
Malignant uterine smooth muscle tumors: role of etoposide, cisplatin, and doxorubicin (EPA) chemotherapy.. 63. 1996
Preliminary results of phase I/II study of high-dose-rate intraoperative radiation therapy for pediatric tumors.. 62. 1996
Tumor necrosis factor alpha stimulates gluconeogenesis from alanine in vivo.. 59. 1995
Ex vivo activated memory T-lymphocytes as adoptive cellular therapy of human soft-tissue sarcoma targets with potentiation by cis-diamminedichloroplatinum(II).. 58. 1995
Innovative technique for division of the dorsal tongue flap.. 57. 1994
Practical management of post-thyroidectomy hematoma.. 57. 1994
Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer.. 56. 1994
Surgical management of accessory parotid tumors.. 54. 1993
Safe ligation of superior thyroid vessels.. 53. 1993
Selective use of drains in thyroid surgery.. 52. 1993
Exposure of the superior thyroid pedicle during thyroidectomy.. 52. 1993
Minimizing the blood loss during flap raising in thyroidectomy.. 52. 1993
Cervical exploration for primary hyperparathyroidism.. 52. 1993
Cancer of the esophagus in young adults.. 50. 1992
Cancer of the esophagus: esophagogastric anastomotic leak--a retrospective study of predisposing factors.. 49. 1992
Marginal mandibulectomy for carcinoma of the floor of the mouth.. 49. 1992
A long-term follow-up of pectoralis osteomyocutaneous flaps.. 49. 1992
The effect of elevated levels of thromboxane on host response to tumor.. 49. 1992
Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor.. 48. 1991
Subtotal submucosal cricoid resection: an experimental study.. 48. 1991
Parathyroid autotransplantation during thyroid surgery.. 46. 1991
Extended neck dissection.. 45. 1990
Recurrence of resected esophagogastric adenocarcinoma: results of re-resection.. 45. 1990
Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma.. 44. 1990
Observations on the natural history and treatment of recurrent major salivary gland cancer.. 44. 1990
Accuracy and pitfalls of frozen section during thyroid surgery.. 44. 1990
Central venous catheter complications in sarcoma patients receiving adjuvant chemotherapy.. 44. 1990
Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer.. 43. 1990
Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients.. 40. 1989
Bladder cancer: pelvic lymphadenectomy revisited.. 37. 1988
A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.. 27. 1984
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate.. 23. 1983
Mercury-induced necrosis of murine renal cell carcinoma.. 18. 1981
Suppressor cells in the pelvic lymph nodes regional to bladder cancer.. 11. 1979
Immunologic reactivity of lymph nodes regional to prostatic cancer: preliminary observations.. 9. 1977
Immunologic response to melanoma of sensitized perfused bone and spleen.. 4. 1972
Value of renography following radical pelvic cancer surgery.. 4. 1972
In response to: Pay attention to EBSLN in anatomical classification of the superior pole in thyroid surgery.. 114. 2016
Sentinel node biopsy for cancer of the oral cavity.. 120. 2019
Remote-access thyroid surgery-progress, assessment, and reflection.. 118. 2018
Implications of extra nodal extension in differentiated thyroid cancer.. 116. 2017
Solid organ transplant and thyroid cancer.. 115. 2017
Revisiting the gastric pull up for pharyngoesophageal reconstruction: A systematic review and meta-analysis of mortality and morbidity.. 114. 2016
Transaxillary thyroidectomy-A critical appraisal.. 111. 2014
Patterns of invasion as major prognostic factors in cancer of the oral cavity.. 109. 2014
Surgical management of metastatic tumors.. 109. 2013
Improving safety in robotic surgery: intraoperative crisis checklist.. 108. 2013
The adrenal gland: fascinating, but still many advances to be made.. 106. 2012
Introduction/Foreword.. 107. 2012
Thymidylate synthase expression in high-grade neuroendocrine and non-small cell lung cancer histotypes--is it ready for primetime?. 102. 2010
Surgical options as quality of care indicators in breast cancer.. 99. 2009
Breast cancer: from radical to minimal surgery.. 98. 2008
A tribute to Jatin P. Shah, MD.. 97. 2008
Radiofrequency ablation for pulmonary metastases: a therapy in evolution.. 96. 2007
Organ-based subspecialization in surgical oncology: fragmentation as a path to progress?. 96. 2007
Papillary microcarcinoma of the thyroid.. 95. 2007
The current status of breast cancer chemoprevention: a star is born.. 95. 2007
Breast conserving therapy: who and why?. 84. 2003
The national cancer data base: what does it mean to the community surgeon?. 73. 2000
Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging. 2018
Modern techniques and alternative flaps in microsurgical breast reconstruction. 2018
Checkpoint blockade in esophagogastric cancer. 2018
Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. 2017
Surgical considerations for papillary thyroid microcarcinomas. 2017
CAR T-cell therapy for pancreatic cancer. 2017
Differences in the multimodal treatment of gastric cancer: East versus west. 2017
Pathophysiology of lymphedema-Is there a chance for medication treatment? 2016
Trends and concepts in post-mastectomy breast reconstruction. 2016
Lymphedema surgery: Patient selection and an overview of surgical techniques. 2016
The importance of surgical margins in retroperitoneal sarcoma. 2015
Soft tissue tumors of the trunk: management of local disease in the breast and chest and abdominal walls. 2014
Margins in breast conservation: a clinician's perspective and what the literature tells us. 2014
Pulmonary metastasectomy. 2013
Management of recurrent retroperitoneal sarcoma. 2013
Peritoneal debulking/intraperitoneal chemotherapy-non-sarcoma. 2013
Surgical management of adrenal metastases. 2013
Management of recurrent rectal cancer: practical insights in planning and surgical intervention. 2013
Surgical management of non-colorectal hepatic metastasis. 2013
Pancreatic metastasectomy: the Memorial Sloan-Kettering experience and a review of the literature. 2013
Thyroid metastasectomy. 2013
Pathologic classification of adenocarcinoma of lung. 2013
Cure models for the analysis of time-to-event data in cancer studies. 2013
Gastric cancer epidemiology and risk factors. 2012
Genomic dysregulation in gastric tumors. 2012
Laparoscopic transabdominal lateral adrenalectomy. 2012
Minimally invasive surgery for gastric cancer. 2012
Ablative therapies in adrenal tumors: primary and metastatic. 2012
Radionuclide therapy of adrenal tumors. 2012
Molecular imaging of adrenal neoplasms. 2012
Epidemiology of pancreatic cancer and the role of family history. 2012
Adrenocortical carcinoma: past, present, and future. 2012
Delphian node metastasis in head and neck cancers--oracle or myth? 2010
Surgical technique refinements in head and neck oncologic surgery. 2010
Induction chemotherapy in the management of head and neck cancer. 2010
Neoadjuvant therapy of locally advanced gastric cancer. 2010
Outcome--more than just operative mortality. 2009
Current status of FDG-PET for head and neck cancer. 2008
Frontiers in free flap reconstruction in the head and neck. 2008
Medical management of thyroid cancer: a risk adapted approach. 2008
Molecular pathogenesis of head and neck cancers. 2008
Staging of head and neck cancers: is it time to change the balance between the ideal and the practical? 2008
Diagnosis and management of lipomatous tumors. 2008
Routine drainage after thyroid surgery--a meta-analysis. 2007
Seminars: local and regional anesthesia for thyroid surgery. 2006
Reconstruction of the hypopharynx with the free jejunum transfer. 2006
Scalp reconstruction. 2006
Vaginal reconstruction: an algorithm approach to defect classification and flap reconstruction. 2006
Current management of mucosal melanoma of the head and neck. 2003
Current status of tamoxifen use: An update for the surgical oncologist. 1999
Special considerations in breast cancer risk and survival. 1999
Craniofacial resection for malignant neoplasms of the skull base: an overview. 1998
Substernal goiter. 1995
Inequities in global cancer surgery: Challenges and solutions. 2023
The African Research Group for Oncology: A decade fostering colorectal cancer research in Nigeria. 2023
Oncologic anthropology: Global variations in breast cancer risk, biology, and outcome. 2023
Epidemiology and incidence of HPV-related cancers of the head and neck. 2021
Hepatic resection for colorectal metastases. 2013
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions. 2011
Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. 2010
Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. 2010

VIVO Weill Cornell Medical College

Journal of surgical oncology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)